An Examination of Infants' Microbiome, Nutrition, and Development Study.
关键词
抽象
描述
The purpose of this study is to determine: 1) how the gut bacteria of exclusively breastfed infants changes in response to ingesting solid foods; 2) how infant cognition develops in response to ingesting solid foods; and 3) the relationship between infant gut bacteria and infant cognition during the first year of life.
This study is designed to determine how specific complex carbohydrates in commonly used first foods encourage the growth of different bacteria in the infant gut. The two foods used in this study are commercially-available sweet potato (Plum Organics) and pear (Earth's Best). These two foods have been chosen because they differ substantially from each other in their carbohydrate composition. For example, sweet potato is mostly made up of starch which is digestible and pear is made up of other types of sugars found in fruits and vegetables that are not digestible and may have "prebiotic" effects (food for good bacteria in the gut). Thus, the use of these two foods could provide a good contrast for comparing how gut bacteria respond to different carbohydrate compositions during complementary feeding.
日期
| 最后验证: | 06/30/2020 |
| 首次提交: | 07/06/2017 |
| 提交的预估入学人数: | 07/23/2017 |
| 首次发布: | 07/25/2017 |
| 上次提交的更新: | 07/22/2020 |
| 最近更新发布: | 07/23/2020 |
| 实际学习开始日期: | 04/17/2017 |
| 预计主要完成日期: | 03/09/2020 |
| 预计完成日期: | 03/09/2027 |
状况或疾病
干预/治疗
Other: Sweet Potatos
Other: Pears
相
手臂组
| 臂 | 干预/治疗 |
|---|---|
| Experimental: Sweet Potatos Infants will consume commercially available baby food sweet potato (SP) (Plum Organics, Just Sweet Potato) for 7 days followed by a 4 day washout period of exclusive breast milk. Participants will be instructed to offer 1-2 tablespoons of sweet potato to their infant at least three times per day for seven days in a row. | Other: Sweet Potatos Plum Organics, Just Sweet Potato |
| Experimental: Pears Infants will consume commercially available baby food pear (P) (Earth's Best, First Pears) for 7 days followed by a 4 day washout period of exclusive breast milk. Participants will be instructed to offer 1-2 tablespoons of pears to their infant at least three times per day for seven days in a row. | Other: Pears Earth's Best, First Pears |
资格标准
| 有资格学习的年龄 | 21 Years 至 21 Years |
| 有资格学习的性别 | Female |
| 接受健康志愿者 | 是 |
| 标准 | Inclusion Criteria: - Women, age 21 to 45 years who have delivered a healthy single infant by vaginal delivery and their infants, age 4 to 7.5 months; - Infants who are developmentally ready for solids; - Generally healthy women and infants; - Mothers who plan to exclusively (without solids or infant formula) breastfeed (at the breast or feed breast milk by bottle) their infants for at least 5 months of age and plan to continue to breastfeed with solids and/or infant formula until 12 months of age; - Mothers who are willing to either use their own breast pump, or hand-express, or use a manual pump provided by the study to collect milk samples; - Mothers who are willing to refrain from feeding their infants infant formula, non-study solid foods; probiotic or iron supplements (confounding variables of the intestinal microbiome) before the end of the feeding intervention period; - Term infants born >37 weeks gestation; - Mother-infant pairs who live within a 20-mile radius from University of California, Davis campus in Davis, California (includes Woodland, Vacaville, Dixon and surrounding areas) or within a 20-mile radius of the University of California, Davis Medical Center (UCDMC) (2221 Stockton Blvd, Sacramento, CA 95817). Exclusion Criteria: - Infants with any GI tract abnormalities; - Infants born by cesarean section; - Family history of immunodeficiency syndrome(s); - Multiple infants born to one mother at the same time (no twins, triplets, etc.); - Infants born with medical complications such as: respiratory distress syndrome, birth defects, and infection; - Mothers diagnosed with any metabolic or endocrine, liver, kidney disease, any autoimmune disease, cirrhosis, hepatitis C, HIV, AIDS, cancer, obesity (pre-pregnancy BMI >34.9), polycystic ovary syndrome (PCOS), celiac disease, Crohn's disease, heart disease, hyper- or hypothyroidism, hyper- or hypotension (including pre-eclampsia), type 1 or type 2 diabetes. - Mothers who smoked cigarettes less than one month before becoming pregnant, during pregnancy, and currently or mothers who plan to initiate smoking during the study duration; - Infants who have taken antibiotics within the past 4 weeks; - Infants who have taken iron supplements within the past 4 weeks; - Infants who have consumed infant formula in the past 4 weeks; - Infants who have consumed infant formula more than 10 days between birth and 4 weeks prior to screening; - Infants who have consumed any solids; - Mothers who plan to feed infants solids before 5 months of age; - Mothers who plan to administer any probiotics to infants throughout the feeding intervention period (first 18 days of the study); - Infants who have consumed probiotics containing Bifidobacterium within the past 4 weeks or other probiotics within the past 7 days; - Mothers who live in more than one location (should only live in one house to ensure samples are correctly collected and stored); - Infants who have hypotonia, - Infants who have been diagnosed with any medical or nutritional condition that would require iron supplementation. - Infants who on average pass less than one stool per week. |
结果
主要结果指标
1. Infant fecal microbiota composition [Change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180]
2. Infant fecal microbial diversity [Change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180]
3. Incidence of Adverse Events and Treatments [Baseline-days 180]
次要成果指标
1. Dietary composition [Change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180]
2. Infant cognition [Change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180]
3. Infant sleep [Change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180]
4. Maternal secretor status and infant fecal microbiota [Change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180]
5. Infant secretor status and fecal microbiota [Change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180]
6. Maternal and infant fecal microbiota [Change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180]
7. Infant fecal human milk oligosaccharide concentrations [Change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180]
8. Infant weight [Change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180]
9. Human milk metabolomics [Change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180]
10. Fecal metabolomics [Change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180]
11. Infant gastrointestinal function [Change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180]
12. Glycosidic linkages [Change from baseline to day 29]
